The potential relationships between the use of hormonal contraception and HIV will be discussed during several sessions of the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa, later this month. The conference programme includes three sessions, an oral presentation and two posters on the topic. The sessions will examine communication and action in the context of uncertainty about hormonal contraceptive use and HIV risk, research on hormonal contraception and HIV, and supporting those affected by HIV to meet their reproductive goals.

 

PowerPoint half_p

Click to view image

 

Sessions
Title: Supporting HIV-affected women and men to safely meet reproductive goals: insights into contraception, safer conception, and infertility
Code: WESY06
Date: Wednesday, 20 July, 16:30-18:00
 .
Title Hormonal contraception and HIV: A review of the science and research, and their implications for research, programme and policy
Code:  THSA09
Date: Thursday, 21 July, 07:00 – 08:30
.
Oral presentations
Title:

Effect of injectable hormonal contraceptives on vaginal epithelium thickness and genital HIV target cell density in women recently infected with HIV 

Note: This presentation is part of the session on Acute HIV Infection: The Battle Begins (WEAA01)

Code: WEAA102
Date: Wednesday, 20 July, 11:15 – 12:30
.
Posters
Title: The association of injectable progestin-only contraceptives and endogenous progestins with HIV target cell frequency in the cervix and HIV acquisition risk
Code: TUPEDA0104 
.
Title: The effect of type of progestin-only contraception (DMPA versus levonorgestrel implant) on HIV shedding in the genital tract of HIV-infected women on antiretroviral therapy
Code: LBPE007
Global Village  
 Title:

One woman, many choices: Hormonal contraception and HIV communication and action in the context of uncertainty

Note: This session will be held in the Research Literacy Zone (Booth 606) in the Global Village.

Date: Monday, 18 July, 11:15-12:15

 

AIDS 2016: Hormonal contraception and HIV